share_log

Aurora Reports 20% YoY Uptick In Global Medical Marijuana, Expects Benefits From International Cannabis Regulatory Reforms

Benzinga ·  Jun 20 20:59

AuroraCannabis Inc. (NASDAQ:ACB) (TSX:ACB) announced its financial and operational results Thursday for thefourth quarter and fiscal year 2024.

The Alberta-based cannabis giant noted the year-over-year comparison quarter for the fourth quarter of 2024 ending March 31, 2024, is the third quarter of fiscal 2023 ending March 31, 2023, as the fiscal year 2023 consisted of three quarters.

The company reported a5% year-over-year increase in revenue to CA$67.4 million ($49.1 million) in the fourth quarter.

Global medical cannabis net revenue grew by 20% over the same period to CA$45.6 million.The increase in net revenue1 of $7.7 million was primarily due to higher sales...

Login or create a forever free account to read this news
Sign up/Log in
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment